Health Discovery Corporation Inks Deal For Final Validation Of A New Molecular Diagnostic Test For Colon Cancer
February 12, 2010 – 11:21 amHealth Discovery Corporation (OTCBB: HDVY) announced today that the Company has entered into an exclusive agreement with the Pancreas, Biliary and Liver Surgery Center of New York at Saint Vincent Catholic Medical Centers in New York City to provide clinical specimens to be utilized to complete the final validation of HDC’s molecular diagnostic test for colon cancer. This test demonstrated a 93% Sensitivity and a 93% Specificity in a previous validation study…
Related Info :
Tags: Biliary, cancer, Clinical Specimens, Colon, Colon Cancer, Colon Health, Corporation, deal, Diagnostic, Diagnostic Test, Discovery, Final, Hdc, Health, Health Discovery, Inks, Liver Surgery, Molecular, New York City, Pancreas, Saint Vincent Catholic Medical Centers, Specificity, Surgery Center, Test, Validation, Validation Study
